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Abstract
Ebolaviruses (EBOV) (family Filoviridae) cause viral hemorrhagic fevers in humans and non-human primates when they spill
over from their wildlife reservoir hosts with case fatality rates of up to 90%. Fruit bats may act as reservoirs of the Filoviridae.
The migratory fruit bat, Eidolon helvum, is common across sub-Saharan Africa and lives in large colonies, often situated in
cities. We screened sera from 262 E. helvum using indirect fluorescent tests for antibodies against EBOV subtype Zaire. We
detected a seropositive bat from Accra, Ghana, and confirmed this using western blot analysis. The bat was also seropositive
for Lagos bat virus, a Lyssavirus, by virus neutralization test. The bat was fitted with a radio transmitter and was last detected
in Accra 13 months after release post-sampling, demonstrating long-term survival. Antibodies to filoviruses have not been
previously demonstrated in E. helvum. Radio-telemetry data demonstrates long-term survival of an individual bat following
exposure to viruses of families that can be highly pathogenic to other mammal species. Because E. helvum typically lives in
large urban colonies and is a source of bushmeat in some regions, further studies should determine if this species forms a
reservoir for EBOV from which spillover infections into the human population may occur.
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Introduction
Marburgvirus (MARV) and Ebolaviruses (EBOV) (family Filoviridae)
can cause viral hemorrhagic fevers in humans and non-human
primates when they spill over from their wildlife reservoir hosts
[1,2,3,4]. Disease outbreaks have case fatality rates in humans of
up to 90%, depending on the viral type. Compelling evidence
exists to suggest that some species of fruit bat act as reservoir hosts
of the Filoviridae [1,2,3,4,5]. Towner et al. isolated virus and
detected nucleic acids of genetically diverse MARV from the cave-
dwelling fruit bat, Rousettus aegyptiacus and LeRoy et al. found
serological and PCR evidence of EBOV infection in three other
fruit bat species in West Africa [1,4]. Subsequently, surveillance
showed a higher seroprevalence against both MARV and EBOV
in R. aegyptiacus than in other species tested [2]. Typically R.
aegyptiacus live in very large roosts, with populations recorded over
100,000, which could facilitate persistence of infection within
roosts.
The tree-roosting fruit bat, Eidolon helvum, is widespread and
common across sub-Saharan Africa. It lives in large colonies,
which sometimes number several million animals, often situated in
cities [6,7,8,9,10]. The species is migratory, possibly in relation to
food availability [8,11]. In West Africa it was shown to migrate
seasonally during the rainy season [8].
Analysis
Ethical approval for this project (WLE/0467) was received from
the Zoological Society of London Ethics Committee.
We screened sera from 262 E. helvum and 3 Hypsignathus
monstrosus using indirect fluorescent tests for antibodies against
EBOV subtype Zaire and MARV subtype Leiden [12]. Blood
samples were collected from E. helvum in Ghana between January
and April 2008 (n=173) from urban colonies in Accra (n=141)
and Kumasi (n=10) and from Tanoboase (n=22) and from Accra
(n=89) in January and February 2009. Samples from 3 H.
monstrosus were collected from Tanoboase in January 2009. The
262 E. helvum samples comprised 2 from neonate, 43 from sexually
immature and 217 from mature bats, with an approxiate 2:1
overall male bias. The 3 H. monstrosus were adult females. Bats
were trapped on return to roosting sites in mist nets. Each bat in a
subsample (n=98) of the E. helvum population in Accra was fitted
with a radio transmitter (Wildlife Materials Inc., Illinois, USA).
Results
One pregnant adult female E. helvum (#49), sampled and
released in Accra in January 2008, had an IgG antibody titer
against EBOV of .1:80, but was seronegative for MARV. All
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positive reactivity for EBOV was confirmed using western blot
against a recombinant nucleocapsid protein of EBOV-Zaire,
which was cloned and produced in an E. coli expression vector with
His tag [13]. A total of 20 mg purified protein was separated in a
preparative gel, followed by blotting and preparation of mem-
brane strips (each containing 1.2–1.4 mg protein). Out of five bat
sera tested (Figure 1), only sample #49 showed a clear and strong
reactivity at a serum dilution of 1:100. This pregnant bat also had
a neutralizing antibody titer of .1:80 against the 1956 Nigerian
Eidolon helvum lyssavirus, Lagos bat virus (LBV), but no antibodies
against Mokola virus using the 1968 Nigerian shrew (Crocidura sp.)
isolate [9]. These bats were part of a large capture-mark-recapture
project monitoring antibody seroprevalence to a range of
pathogens and therefore no tissues were collected and insufficient
heat-treated sera were available for RT-PCR. The EBOV-
seropositive bat had been fitted with a radio transmitter and was
last detected (using a SIKA Radio Tracking Receiver, BioTrack,
Dorset, UK) in Accra in March 2009 (Figure 2) after which the
colony migrated for the second time during the study. Weekly
efforts were made to detect it until August 2009, but ceased due to
the estimated battery life of the collar being 491 days. Therefore
the animal will not be detected again even if it survives and returns
to Accra from migration.
Discussion
The novel finding in this study was that an individual female E.
helvum, which had specific antibodies to both EBOV-Zaire and
LBV, was alive over 13 months post-sampling. This bat appeared
to be healthy and showed typical migratory movements for E.
helvum in this region of West Africa [8] (Figure 2). Athough fruit
bats seropositive to EBOV and MARV have been detected
elsewhere, antibodies to filoviruses have not been previously
demonstrated in E. helvum, including E. helvum sympatric with R.
aegyptiacus seropositive to EBOV and MARV [2], and long-term
survival of seropositive bats has not previously been shown.
Fruit bats are recognised reservoirs of lyssaviruses and henipa-
viruses, and can have high viral seroprevalences [9,10,14]. In
contrast, most studies have reported that filovirus seroprevalence in
bats is low (,10%) [1,2,3,4,15], although 24% H. monstrosus were
found to be positive against EBOV following an EBOV epidemic in
humans, and where PCR-positive bats were detected in the region
shortly after the outbreak, suggesting recent virus circulation [4].
The positive predictive values of tests used in all of these studies are
unknown. In the absence of a population of E. helvum known to be
uninfected, formal investigation of specificity in our study is
impossible. Similarly, the sensitivities of filovirus serological assays
on bat samples are unknown. Efforts to ensure that results are
accurate here were based on good laboratory approach and the use
of western blot analysis to confirm IFA results.
One in 262 sera is clearly a low seroprevalence and it is likely that
virus prevalence is extremely low in E. helvum in Ghana. Prevalences
of other bat viruses, such as lyssaviruses and henipaviruses, for
example,arevery loweven when seroprevalencesarerelativelyhigh
(e.g. around 40%) [14,16,17,18,19,20,21]. Western blot analysis
indicated that the antibody response in our study was specific to
EBOV-Zaire, which is highly pathogenic to people, rather than to
EBOV-Reston (data not shown), which has low pathogenicity in
humans and which has not been detected in Africa [22]. Whilst the
pathogenicity of EBOV-Zaire to E. helvum cannot be determined by
our study, the presence of detectable anti-EBOV antibody
demonstrates that there has been sufficient exposure to viral antigen
Figure 1. Western blot analysis using a recombinant nucleo-
protein protein of EBOV-Zaire. The five bat sera (bat serum #46,
48, 49, 50 and 53, respectively) were tested at 1:100. The positive
control antibody (anti-RGS-His monoclonal antibody, Invitrogen, USA)
in strip 6 was tested at 1:600. The numbers on the left are molecular
masses in kDa derived from the BenchMark Pre-stained molecular
markers (Invitrogen, USA).
doi:10.1371/journal.pone.0011978.g001
Figure 2. Weekly presence determined by radio-telemetry of the female Eidolon helvum in central Accra, Ghana. The bat was
determined to be seropositive against both Ebolavirus subtype Zaire and Lagos Bat Virus (Nigeria 1956 isolate). The bat was pregnant when sampled
in January 2008. Monthly mean rainfall is shown in mm (data from World Weather Information Service).
doi:10.1371/journal.pone.0011978.g002
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most parsimonious explanation is infection followed by sufficient
virus replication for the animal to mount an adaptive immune
response. Insufficient data exist to determine if infection of E. helvum
with EBOV can be productive, thus enabling it to serve as an
effective reservoir for EBOV, or if this species develops clinical signs
when infected with EBOV. Also, studies in individual bat roosts
should not be extrapolated to all bats or roosts of that species, but
population level infection dynamics must be considered when
determining the reservoir status of a species.
Spillover of infection into a large susceptible population, such as
E. helvum, which roosts in urban areas, must be considered a
possible public health risk. Because E. helvum typically lives in large
urban colonies and is a source of bushmeat in some regions [9]
and direct bat to human transmission of EBOV has been reported
[5], further studies should determine if this species forms a
reservoir for EBOV from which spillover infections into the
human population may occur.
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